P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma
Cheng Cheng(Shanghai Jiao Tong University), Zhixiang Wu(XinHua Hospital)
Cited by 15
Related Papers
XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor
|Journal of Experimental & Clinical Cancer Research|2021|29